Gastric cancer
Conditions
Interventions
Oral intake of leucine-rich amino acid from POD-1 to POD 30.
Enhanced exercise from POD 1 to day of discharge.
Sponsors
Osaka medical college, General and Gastroenterological Surgery
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1)Patients with radical surgery is scheduled. 2)ASA(American Society of Anesthesiology)class 1-3. 3)T factor T1a-T4a. 4)Weight loss rate the month prior to surgery is within 10%. 5)Written informed consent must be obtained from patients.
Exclusion criteria
Exclusion criteria: 1)Patients with severe complications. 2)Requiring resection the other organs except the gallbladder. 3)Patients with infection in progress. 4)Emergency surgery. 5)Patients with uncontrolled diabetes. 6)Patients enrollment to the study is determined to be inappropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The ratio of skeletal muscle mass at 1 month after surgery to preoperative mass | — |
Secondary
| Measure | Time frame |
|---|---|
| The ratio of body weight at 1 month after surgery to preoperative weight Postoperative complications Postoperative hospital stay Nutritional parameters (albumin, transthyretin, total protein, lymphocyte counts) Ingestion rate of leucine-rich amino acid Continuation rate of postoperative adjuvant chemotherapy | — |
Countries
Japan
Contacts
Public ContactRyo Tanaka
Osaka medical college General and Gastroenterological Surgery
Outcome results
None listed